California’s Medicaid program spent the most of all states on GLP-1 coverage, exceeding $1.4 billion, or $118 per enrollee.

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The director of medical weight management at West Virginia University says a canceled pilot program that provided weight-loss drugs to state employees showed “incredible” results, with patients losing ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

Connecticut law requires Medicaid to cover certain weight loss drugs, but officials say it hasn't been happening due to cost ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Investopedia ranks AARP/UnitedHealthcare as the best Medicare Supplement (Medigap) insurance provider. Other winners include ...